![]() |
|
|








,3
* Graduate Center for Nutritional Sciences
Molecular and Cell Nutrition Laboratory, College of Agriculture, Departments of

Pediatrics

Cardiovascular Medicine, and
# Surgery, University of Kentucky, Lexington, KY 40546;
** Department of Food Sciences, University of Missouri-Columbia, Columbia, MO 65211; and
Department of Medicine, Vanderbilt University, Nashville, TN 37232
3To whom correspondence should be addressed. E-mail: bhennig{at}uky.edu.
Low zinc concentration can be associated with an increased risk of cardiovascular diseases. In the current study, we hypothesize that zinc deficiency can increase and zinc supplementation can decrease proatherosclerotic events in LDL receptor knock-out (LDL-R/) mice fed a moderate-fat diet. Mice were fed either a zinc-deficient (0 µmol Zn/g), a control (0.45 µmol Zn/g), or a zinc-supplemented (1.529 µmol Zn/g) diet for 4 wk. Mice fed the zinc-deficient diet had significantly increased concentrations of cholesterol and triacylglycerides in the VLDL and HDL fractions. Zinc supplementation decreased these lipid variables compared with control mice. We detected significantly higher concentrations of glutathione reductase mRNA in the thoracic aortae of zinc-deficient mice. Furthermore, inflammatory markers, such as nuclear factor-
B and vascular cell adhesion molecule-1, were significantly increased in zinc-deficient mice compared with mice of the control or supplemented groups. In addition, zinc deficiency significantly reduced the DNA binding activity of peroxisome proliferator activate receptors (PPARs) in liver extracts. Interestingly, mRNA expression levels of PPAR
were significantly increased in thoracic aortae of zinc-deficient mice, indicating an adaptation process to decreased PPAR signaling. These data provide in vivo evidence of zinc deficiency inducing proinflammatory events in an atherogenic mouse model. These data also suggest that adequate zinc may be a critical component in protective PPAR signaling during atherosclerosis.
KEY WORDS: zinc deficiency atherosclerosis inflammation PPAR lipoproteins
This article has been cited by other articles:
![]() |
N. Stadler, N. Stanley, S. Heeneman, V. Vacata, M. J.A.P. Daemen, P. G. Bannon, J. Waltenberger, and M. J. Davies Accumulation of Zinc in Human Atherosclerotic Lesions Correlates With Calcium Levels But Does Not Protect Against Protein Oxidation Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 1024 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, R. MacDonald, D. Bruemmer, A. Stromberg, A. Daugherty, X.-a. Li, M. Toborek, and B. Hennig Zinc Deficiency Alters Lipid Metabolism in LDL Receptor Deficient Mice Treated with Rosiglitazone J. Nutr., November 1, 2007; 137(11): 2339 - 2345. [Abstract] [Full Text] [PDF] |
||||